產(chǎn)品展示
- 重組人干擾素誘導(dǎo)蛋白-10?????Recombinant Human IP-10(CXCL10)300-125ug/25ug/Peprotech時(shí)間:2025-09-30型號(hào):廠商性質(zhì):代理商瀏覽量:1756
- 重組人干擾素誘導(dǎo)蛋白-10?????Recombinant Human IP-10(CXCL10)300-125ug/25ug/Peprotech時(shí)間:2025-09-30型號(hào):廠商性質(zhì):代理商瀏覽量:1788
- 重組人干擾素誘導(dǎo)蛋白-10?????Recombinant Human IP-10(CXCL10)300-125ug/25ug/Peprotech時(shí)間:2025-09-30型號(hào):廠商性質(zhì):代理商瀏覽量:1993
- 重組人干擾素誘導(dǎo)蛋白-10?????Recombinant Human IP-10(CXCL10)300-125ug/25ug/Peprotech時(shí)間:2025-09-30型號(hào):廠商性質(zhì):代理商瀏覽量:1796
- 重組人干擾素誘導(dǎo)蛋白-10?????Recombinant Human IP-10(CXCL10)300-125ug/25ug/Peprotech時(shí)間:2025-09-30型號(hào):廠商性質(zhì):代理商瀏覽量:1679
- 重組人白介素-8(77a.a.)Recombinant Human IL-8(77a.a)(CXCL8)200-085ug/25ug/Peprotech時(shí)間:2025-09-30型號(hào):廠商性質(zhì):代理商瀏覽量:1789
- 重組人白介素-8(77a.a.)Recombinant Human IL-8(77a.a)(CXCL8)200-085ug/25ug/Peprotech時(shí)間:2025-09-30型號(hào):廠商性質(zhì):代理商瀏覽量:1777
- 重組人白介素-8(77a.a.)Recombinant Human IL-8(77a.a)(CXCL8)200-085ug/25ug/Peprotech時(shí)間:2025-09-30型號(hào):廠商性質(zhì):代理商瀏覽量:1925

